Search International and National Patent Collections

1. (WO2018064945) PHARMACEUTICAL COMPOSITION

Pub. No.:    WO/2018/064945    International Application No.:    PCT/CN2017/103651
Publication Date: Fri Apr 13 01:59:59 CEST 2018 International Filing Date: Thu Sep 28 01:59:59 CEST 2017
IPC: A61K 31/497
A61K 31/4245
A61K 31/4164
A61K 31/501
A61K 31/216
A61K 31/192
A61K 31/197
A61P 9/12
A61P 9/04
Applicants: WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD.
武汉朗来科技发展有限公司
WUHAN QR PHARMACEUTICALS CO., LTD.
武汉启瑞药业有限公司
Inventors: WANG, Chaodong
王朝东
CHEN, Yongkai
陈永凯
HU, Liu
胡柳
ZENG, Xian
曾弦
KANG, Daiwu
康代武
Title: PHARMACEUTICAL COMPOSITION
Abstract:
The present invention relates to a pharmaceutical composition comprising: (a) at least one neutral endopeptidase inhibitor or a pharmaceutically acceptable salt or ester thereof, (b) at least one compound represented by formula (I) or a pharmaceutically acceptable salt or ester thereof, and a pharmaceutically acceptable carrier. Combined administration showed better medicinal effects than separate administration.